INFIRST+
Live / Registered — Registered (as of 13 Jan 2026)
What this means for you
Registered since 13 Jan 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 13 Jan 2032: the §8 declaration of use).
Record
- Serial number
- 98390551
- Registration number
- 8103735
- Mark type
- Word mark
- Filed
- 04 Feb 2024
- Published for opposition
- 29 Oct 2024
- Registered
- 13 Jan 2026
- Next maintenance filing
- §8 declaration of use, due by 13 Jan 2032 (grace period to 13 Jul 2032)
- Attorney of record
- Dean G. Stathakis
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of cancer, cardiovascular, endocrine or hormonal, gastrointestinal, inflammatory, musculoskeletal, microbial, neurodegenerative, neurological, pain, respiratory, skin, urological conditions, diseases and disorders; Pharmaceutical preparations for inflammatory relief; pain relief medications; headache and migraine treatment preparations; Pharmaceutical preparations for fever relief and the treatment of cough and cold; Pharmaceutical preparations for the treatment of heartburn, upset stomach, gastroesophageal reflux, acid reflux, acid indigestion relief, abdominal and stomach bloating, pain, and excessive gas build-up relief; diarrhea relief medications; Pharmaceutical preparations for the treatment of anti-microbial, anti-viral, and anti-bacterial infections; burn relief medications; acne treatment medications for acne relief, allergy relief medications
Owner
- Infirst Healthcare Inc., Westport, CT
- Infirst Healthcare Inc., Westport, CT
- Infirst Healthcare Inc., Westport, CT
Prior registrations
Prosecution history
- 13 Jan 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 13 Jan 2026 — REGISTERED-PRINCIPAL REGISTER
- 19 Dec 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 19 Dec 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 13 Dec 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 16 Jun 2025 — USE AMENDMENT FILED
- 12 Dec 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Jun 2025 — TEAS STATEMENT OF USE RECEIVED
- 10 Jun 2025 — SOU EXTENSION 1 GRANTED
- 10 Jun 2025 — SOU EXTENSION 1 FILED
- 10 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 10 Dec 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 29 Oct 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 29 Oct 2024 — PUBLISHED FOR OPPOSITION